Dec 12, 2013

Japan panel misled over cervical cancer vaccine decision

An article about the cervical cancer vaccine Cervarix that was used by a health ministry panel to justify subsidies for the drug was written by an employee of its manufacturer, GlaxoSmithKline K.K., informed sources said. According to the Japanese unit of Britain’s GlaxoSmithKline PLC, ...